Liver Slice Technology as an In Vitro Model for Metabolic and Toxicity Studies

2003 ◽  
pp. 291-304
Author(s):  
Sanjeev Thohan ◽  
Gerald M. Rosen
2014 ◽  
Vol 28 (1) ◽  
pp. 104-112 ◽  
Author(s):  
Daniel Mueller ◽  
Lisa Krämer ◽  
Esther Hoffmann ◽  
Sebastian Klein ◽  
Fozia Noor

Hepatology ◽  
2003 ◽  
Vol 38 ◽  
pp. 780-781
Author(s):  
J DAVIES ◽  
C VERRILL ◽  
H MILLWARDSADLER ◽  
L SUNDSTROM ◽  
N SHERON

2011 ◽  
Vol 1 (2) ◽  
pp. S216-S219 ◽  
Author(s):  
M Kalaiselvi ◽  
R Narmadha ◽  
P Ragavendran ◽  
Arul Raj ◽  
D Sophia ◽  
...  

2021 ◽  
Vol 22 (13) ◽  
pp. 7137
Author(s):  
Liza Dewyse ◽  
Hendrik Reynaert ◽  
Leo A. van Grunsven

Thirty-five years ago, precision-cut liver slices (PCLS) were described as a promising tool and were expected to become the standard in vitro model to study liver disease as they tick off all characteristics of a good in vitro model. In contrast to most in vitro models, PCLS retain the complex 3D liver structures found in vivo, including cell–cell and cell–matrix interactions, and therefore should constitute the most reliable tool to model and to investigate pathways underlying chronic liver disease in vitro. Nevertheless, the biggest disadvantage of the model is the initiation of a procedure-induced fibrotic response. In this review, we describe the parameters and potential of PCLS cultures and discuss whether the initially described limitations and pitfalls have been overcome. We summarize the latest advances in PCLS research and critically evaluate PCLS use and progress since its invention in 1985.


Author(s):  
Sreenivasa C. Ramaiahgari ◽  
Michiel W. den Braver ◽  
Bram Herpers ◽  
Valeska Terpstra ◽  
Jan N. M. Commandeur ◽  
...  

Author(s):  
Hoda Keshmiri Neghab ◽  
Mohammad Hasan Soheilifar ◽  
Gholamreza Esmaeeli Djavid

Abstract. Wound healing consists of a series of highly orderly overlapping processes characterized by hemostasis, inflammation, proliferation, and remodeling. Prolongation or interruption in each phase can lead to delayed wound healing or a non-healing chronic wound. Vitamin A is a crucial nutrient that is most beneficial for the health of the skin. The present study was undertaken to determine the effect of vitamin A on regeneration, angiogenesis, and inflammation characteristics in an in vitro model system during wound healing. For this purpose, mouse skin normal fibroblast (L929), human umbilical vein endothelial cell (HUVEC), and monocyte/macrophage-like cell line (RAW 264.7) were considered to evaluate proliferation, angiogenesis, and anti-inflammatory responses, respectively. Vitamin A (0.1–5 μM) increased cellular proliferation of L929 and HUVEC (p < 0.05). Similarly, it stimulated angiogenesis by promoting endothelial cell migration up to approximately 4 fold and interestingly tube formation up to 8.5 fold (p < 0.01). Furthermore, vitamin A treatment was shown to decrease the level of nitric oxide production in a dose-dependent effect (p < 0.05), exhibiting the anti-inflammatory property of vitamin A in accelerating wound healing. These results may reveal the therapeutic potential of vitamin A in diabetic wound healing by stimulating regeneration, angiogenesis, and anti-inflammation responses.


Sign in / Sign up

Export Citation Format

Share Document